. Author manuscript; available in PMC: 2011 May 31.

Published in final edited form as: Adv Drug Deliv Rev. 2008 Dec 16;61(1):3–13. doi: 10.1016/j.addr.2008.11.003

Table 1.

Selected non-chemotherapy substrates of ABCG2

Antivirals:

Zidovudine (AZT)

Lamivudine

Abacavir

HMG-CoA reductase inhibitors:

Rosuvastatin

Pitavastatin

Cerivastatin

Carcinogens:

Aflatoxin B1

2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)

2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)

2-amino-3-methylimidazo[4,5-f]quinoline(IQ)

3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1)

Antibiotics:

Ciprofloxacin

Ofloxacin

Norfloxacin

Erythromycin

Nitrofurantoin

Calcium Channel Blockers:

Azidopine

Dipyridamole

Nitrendipene

Other compounds:

Sulfasalazine

Cimetidine

Riboflavin

Vitamin K3

Glyburide

d-Luciferin